Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oncogene ; 36(5): 606-617, 2017 02 02.
Artigo em Inglês | MEDLINE | ID: mdl-27775079

RESUMO

Medulloblastoma (MB), the most common malignant paediatric brain tumor, is currently treated using a combination of surgery, craniospinal radiotherapy and chemotherapy. Owing to MB stem cells (MBSCs), a subset of MB patients remains untreatable despite standard therapy. CD133 is used to identify MBSCs although its functional role in tumorigenesis has yet to be determined. In this work, we showed enrichment of CD133 in Group 3 MB is associated with increased rate of metastasis and poor clinical outcome. The signal transducers and activators of transcription-3 (STAT3) pathway are selectively activated in CD133+ MBSCs and promote tumorigenesis through regulation of c-MYC, a key genetic driver of Group 3 MB. We screened compound libraries for STAT3 inhibitors and treatment with the selected STAT3 inhibitors resulted in tumor size reduction in vivo. We propose that inhibition of STAT3 signaling in MBSCs may represent a potential therapeutic strategy to treat patients with recurrent MB.


Assuntos
Antígeno AC133/biossíntese , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/patologia , Meduloblastoma/tratamento farmacológico , Meduloblastoma/patologia , Recidiva Local de Neoplasia/patologia , Células-Tronco Neoplásicas/patologia , Fator de Transcrição STAT3/antagonistas & inibidores , Antígeno AC133/imunologia , Animais , Neoplasias Encefálicas/imunologia , Linhagem Celular Tumoral , Proliferação de Células/fisiologia , Feminino , Xenoenxertos , Humanos , Masculino , Meduloblastoma/imunologia , Camundongos , Recidiva Local de Neoplasia/imunologia , Células-Tronco Neoplásicas/imunologia , Células-Tronco Neoplásicas/metabolismo , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais , Bibliotecas de Moléculas Pequenas/farmacologia , Regulação para Cima
2.
Oncogenesis ; 5: e208, 2016 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-26999717

RESUMO

Triple-negative breast cancers (TNBCs) represent a subset of breast tumors that are highly aggressive and metastatic, and are responsible for a disproportionate number of breast cancer-related deaths. Several studies have postulated a role for the epithelial-to-mesenchymal transition (EMT) program in the increased aggressiveness and metastatic propensity of TNBCs. Although EMT is essential for early vertebrate development and wound healing, it is frequently co-opted by cancer cells during tumorigenesis. One prominent signaling pathway involved in EMT is the transforming growth factor-ß (TGFß) pathway. In this study, we report that the novel POZ-ZF transcription factor Kaiso is highly expressed in TNBCs and correlates with a shorter metastasis-free survival. Notably, Kaiso expression is induced by the TGFß pathway and silencing Kaiso expression in the highly invasive breast cancer cell lines, MDA-MB-231 (hereafter MDA-231) and Hs578T, attenuated the expression of several EMT-associated proteins (Vimentin, Slug and ZEB1), abrogated TGFß signaling and TGFß-dependent EMT. Moreover, Kaiso depletion attenuated the metastasis of TNBC cells (MDA-231 and Hs578T) in a mouse model. Although high Kaiso and high TGFßR1 expression is associated with poor overall survival in breast cancer patients, overexpression of a kinase-active TGFßR1 in the Kaiso-depleted cells was insufficient to restore the metastatic potential of these cells, suggesting that Kaiso is a key downstream component of TGFß-mediated pro-metastatic responses. Collectively, these findings suggest a critical role for Kaiso in TGFß signaling and the metastasis of TNBCs.

3.
Eur Rev Med Pharmacol Sci ; 19(11): 2031-5, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26125266

RESUMO

OBJECTIVE: A lower risk of celiac disease (CD) in patients with Helicobacter pylori (Hp) infection has been reported when Hp infection prevalence in CD patients was compared against CD-negative symptomatic persons with indications for diagnostic gastroduodenoscopy. Therefore, we aimed to determine Hp infection frequency in a group of pediatric CD patients at diagnosis and to compare obtained results to data coming from age-matched healthy population. PATIENTS AND METHODS: The study population consisted of 74 CD subjects aged 3 to 12 years in whom the presence of Hp was diagnosed routinely in the course of differential diagnosis with the use of stable isotope breath test which is the gold standard. The control group consisted of 296 healthy age-matched subjects. RESULTS: Hp infection was diagnosed in 4 CD patients and 20 healthy subjects. Its prevalence in CD patients and HS did not differ neither in the entire age group undergoing comparison (5.4% vs. 6.8%, p = 0.5713) nor in the selected age subgroups (3-6 years: 2.5% vs. 3.7%, p = 0.8551; 7-12 years: 8.8% vs. 11.0%, p = 0.8742). CONCLUSIONS: The prevalence of Hp infection in CD patients does not seem to be different than that in general population. However, further studies are needed to assess the potential role of Hp in the pathogenesis of CD.


Assuntos
Doença Celíaca/complicações , Doença Celíaca/epidemiologia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/epidemiologia , Helicobacter pylori , Testes Respiratórios , Doença Celíaca/diagnóstico , Criança , Pré-Escolar , Feminino , Infecções por Helicobacter/diagnóstico , Humanos , Masculino , Prevalência
4.
Eur Rev Med Pharmacol Sci ; 18(16): 2343-8, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25219836

RESUMO

OBJECTIVES: Only recently it has been proven that cystic fibrosis (CF) patients have the same prevalence of Helicobacter pylori (HP infection) as the general population, as well as the same spectrum of changes caused by this pathogen. The aim of this study was to assess the reliability of the two most popular noninvasive tests--the urea breath test (UBT) and the fecal test (FT) in diagnosing HP infection in CF patients. PATIENTS AND METHODS: The study was conducted on 79 CF patients and 49 healthy subjects (HS). The presence of HP infection was evaluated using the 13C isotope-labeled urea breath test and the fecal test (ELISA). RESULTS: Fifteen (19.0%) CF patients and eight (16.3%) HS were found to be HP positive using the UBT. The HP stool antigen was detected in twelve (15.2%) CF patients and seven (14.3%) HS. Discordant results for the two tests were obtained in 9 out of 18 (50.0%) CF patients and 3 out of 9 (33.3%) HS. Although the differences were not statistically significant, the risk of potentially false negative and false positive results in CF subjects seems to be high. Similarly, no statistical differences in the basic clinical parameters were documented between the CF subgroups with concordant and divergent HP results. CONCLUSIONS: Since there is convincing evidence of divergent UBT and FT results in the CF patients, we suggest that UBT is kept as the standard method for HP detection in this population, at least until obtaining reliable and valid results allows for a change in such an approach.


Assuntos
Fibrose Cística/epidemiologia , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/epidemiologia , Helicobacter pylori , Adolescente , Adulto , Antígenos de Bactérias/análise , Testes Respiratórios , Criança , Pré-Escolar , Fezes/química , Feminino , Infecções por Helicobacter/imunologia , Helicobacter pylori/imunologia , Humanos , Masculino , Prevalência , Ureia/análise , Adulto Jovem
5.
Clin Exp Immunol ; 177(3): 598-602, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24773566

RESUMO

Persistent presence of ATP4A autoantibodies (ATP4AA) directed towards parietal cells is typical for atrophic body gastritis (ABG), an autoimmune disease associated with type 1 diabetes. We assessed whether Helicobacter pylori (Hp) infection might be associated with positivity for ATP4AA in children with type 1 diabetes. Sera were collected from 70 (38♀) type 1 diabetes children [aged 13·2 ± 4·5 years, age at diagnosis 8·8 ± 4·3 years, diabetes duration 4·5 ± 3·8 years, mean HbA1c 7·8 ± 1·6% (62 ± 17·5 mmol/mol)] seen at the regional diabetes clinic in Katowice, Poland. Patients were tested concurrently for Hp infection by means of a 13C urea breath test. ATP4AA were measured using a novel radioimmunoprecipitation assay developed at the Barbara Davies Center for Childhood Diabetes, University of Colorado. ATP4AA were present in 21 [30%, 95% confidence interval (CI) = 19-41%] and Hp infection was detected in 23 (33%, 95% CI = 22-44%) children. There was no statistically significant association between ATP4AA presence and Hp status. ATP4AA presence was not associated with current age, age at type 1 diabetes diagnosis, diabetes duration or current HbA1c. ATP4AA were more prevalent in females [42% (26-58%)] than males [16% (3-28%)], P = 0·016. ATP4A are found in nearly one-third of children with type 1 diabetes and more common among females. In this cross-sectional analysis, Hp infection was not associated with autoimmunity against parietal cells.


Assuntos
Autoimunidade , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/microbiologia , ATPase Trocadora de Hidrogênio-Potássio/imunologia , Infecções por Helicobacter/microbiologia , Helicobacter pylori , Adolescente , Doenças Autoimunes/imunologia , Doenças Autoimunes/microbiologia , Criança , Pré-Escolar , Estudos Transversais , Feminino , ATPase Trocadora de Hidrogênio-Potássio/sangue , Infecções por Helicobacter/imunologia , Humanos , Masculino , Fatores Sexuais , Adulto Jovem
6.
Folia Neuropathol ; 51(3): 189-202, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24114636

RESUMO

Cellular mechanisms of regeneration after the white matter injury are difficult to study because of severe, inflammatory response to massively damaged myelin. Myelin-lacking CNS of the adult Long Evans Shaker (LES) rat supplies a model where neuroregeneration can be studied conveniently. The crush site in the dorsal spinal column in LES rats implanted with the normal rat choroid plexus was studied under the light and electron microscopy at 5 time points 3-56 days post-op. While the crush injury in normal rats resulted in severe inflammation active beyond 8 weeks, the same injury in LES rats resulted in a brief inflammation that resolved before day 7 post-op. In a clear fluid-filled crush cavity, ependymal cells from the implanted choroid plexus encased multiple regenerating axons, apparently guided them across the crush cavity and participated in establishing of a zone of neuroregeneration, morphologically similar to the white matter, at the interface of the crush cavity and the surrounding tissue of the spinal cord. Axons that were not encased by implanted cells failed to cross the crush cavity and persisted as markedly swollen end bulbs filled with organelles. At 8 weeks post-op, a large proportion of axons in the zone of neuroregeneration became myelinated by Schwann cells, likely originating from dorsal nerve roots or by oligodendrocytes that formed thin sheaths with a major dense line and likely originated from the implanted choroid plexus. The LES rat can serve as a convenient model to study mechanisms of neuroregeneration including axonal regeneration in the adult CNS injury.


Assuntos
Fibras Nervosas Mielinizadas/fisiologia , Regeneração Nervosa/fisiologia , Traumatismos da Medula Espinal/fisiopatologia , Envelhecimento , Animais , Axônios/fisiologia , Transplante de Tecido Encefálico , Plexo Corióideo/fisiologia , Modelos Animais de Doenças , Compressão Nervosa , Ratos , Ratos Mutantes
7.
Oncogene ; 31(2): 187-99, 2012 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-21685941

RESUMO

Bmi1 is a key stem cell regulatory gene implicated in the pathogenesis of many aggressive cancers, including medulloblastoma. Overexpression of Bmi1 promotes cell proliferation and is required for hedgehog (Hh) pathway-driven tumorigenesis. This study aimed to determine if Sonic hedgehog (Shh) modulates the key stem cell regulatory gene Bmi1 in childhood medulloblastoma brain tumor-initiating cells (BTICs). Although current literature suggests that there is a correlation between Shh pathway genes and Bmi1 expression, it is unclear whether there is indeed a direct regulatory mechanism. To address whether Shh induces expression of Bmi1, stem cell-enriched populations from medulloblastoma cell lines and primary samples were treated with Shh ligand and KAAD-cyclopamine (Shh antagonist). Our data indicate that Bmi1 expression positively correlates with increasing Shh ligand concentrations. Chromatin immunoprecipitation reveals that Gli1 preferentially binds to the Bmi1 promoter, and Bmi1 transcript levels are increased and decreased by Gli1 overexpression and downregulation, respectively. Knockdown experiments of Bmi1 in vitro and in vivo demonstrate that Hh signaling not only drives Bmi1 expression, but a feedback mechanism exists wherein downstream effectors of Bmi1 may, in turn, activate Hh pathway genes. These findings implicate Bmi1 and Hh as mutually indispensable pathways in medulloblastoma BTIC maintenance. Recent molecular characterization of medulloblastoma also reveals that Bmi1 is overexpressed across all subgroups of medulloblastoma, particularly in the most aggressive subtypes. Lastly, despite recent identification of BTIC markers, the molecular characterization of these cell populations remains unclear. In this work, we propose that the BTIC marker CD133 may segregate a cell population with a Hh-receptor phenotype, thus demonstrating a cell-cell interaction between the CD133+ Hh receptor cells and the CD133- Hh-secreting cells.


Assuntos
Neoplasias Encefálicas/metabolismo , Proteínas Hedgehog/fisiologia , Meduloblastoma/metabolismo , Proteínas Nucleares/fisiologia , Proteínas Proto-Oncogênicas/fisiologia , Proteínas Repressoras/fisiologia , Neoplasias Encefálicas/patologia , Linhagem Celular Tumoral , Proliferação de Células , Técnicas de Silenciamento de Genes , Humanos , Meduloblastoma/patologia , Proteínas Nucleares/genética , Complexo Repressor Polycomb 1 , Proteínas Proto-Oncogênicas/genética , Proteínas Repressoras/genética
8.
Adv Med Sci ; 56(2): 151-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22008313

RESUMO

PURPOSE: Eosinophilic esophagitis (EoE) is a chronic disease characterized by eosinophilic infiltration of the esophageal mucosa, which is associated with clinical and endoscopic manifestations. The objective of our study was to determine the frequency of EoE and to outline the clinical manifestations of EoE in Polish children. MATERIAL/METHODS: Ten large regional pediatric gastroenterology centers participated in the study. A database of endoscopy reports from January 2004 till December 2009 was reviewed. A total of 35,631 esophagogastroduodenal endoscopy studies in children, aged from 4 months to 18 years, were performed. Data pertaining to the children's age, gender, indications for endoscopy, clinical findings and histopathology diagnosis were made. RESULTS: In 84 children (20 girls and 64 boys), aged between 4 months and 18 years, EoE was diagnosed. This constituted one case per 424 endoscopic studies. In children with changes in the esophageal mucosa the frequency of EoE was higher and reached one case per 73 children. The most frequent symptoms of EoE differed between the younger (1-6 years old) and older children (aged 13-18 years old). Feeding aversion, vomiting and/or regurgitation were most frequently observed in the younger children, while in older children: abdominal pain, dysphagia and chest pain. Granular mucosa, longitudinal furrows, and mucosal rings belong to the findings most often observed in endoscopic studies. EoE was more frequently diagnosed in the spring (45.2%) and summer (28.5%). CONCLUSIONS: EoE was diagnosed in every age, with frequency of 1/424 gastrointestinal endoscopies, more frequently in boys than in girls.


Assuntos
Endoscopia/métodos , Esofagite Eosinofílica/diagnóstico , Esofagite Eosinofílica/epidemiologia , Adolescente , Criança , Pré-Escolar , Esôfago/patologia , Feminino , Gastroenterologia/métodos , Humanos , Lactente , Masculino , Mucosa/metabolismo , Polônia , Estudos Retrospectivos , Estações do Ano
9.
Int J Immunopathol Pharmacol ; 19(3): 489-98, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17026833

RESUMO

AIT-082 is a purine derivative with neuroprotective and neurotrophic activity that is desirable in a candidate therapy for Amyotrophic Lateral Sclerosis. Consequently, we investigated the effect of AIT-082 in a transgenic mouse model of ALS. AIT-082 (0, 1, 3, 10, 30, 60, 100 mg/kg) was given to TgN(SOD1-G93A)1Gur transgenic mice from age 30 days until death. The age at onset of clinical signs of disease and the age at death were recorded for each animal. Disease progression was measured by the weekly average distance run in a running wheel. Analysis was made by the Kaplan Meier method with log rank statistics, log rank for trend and Cox regression. Neuropathological study of the brain, spinal cord, muscles and other organs was undertaken at death. In a second experiment we studied the effect of AIT-082 (30 mg/kg) at the onset of disease and during survival of transgenic G93A SOD1 mice, beginning dosing at different ages (20, 30, 40, 60, 80 days). Disease onset was mildly earlier (i.e. worse) at 1 and 10 mg/kg AIT-082 and mildly delayed at 30 mg/kg. This improvement did not reach the usual statistical significance. There was no difference in the age at death for any treatment dose. There was no difference in the neuropathology of treated and untreated G93A mice. However, there was an early improvement in the running wheel function at all tested doses. Using Cox regression, after adjustment for sex, the mice in the running wheels had slightly delayed onset of disease without change in survival and, after adjustment for exercise, the female mice had slightly improved survival. Consequently, AIT-082 would not be an attractive candidate for ALS clinical trials as monotherapy and justification for its use in combination therapy would require additional laboratory support. There was dissociation between the endpoints of disease progression (as judged by running wheel performance) and disease onset and survival. AIT-082 improved early running wheel performance yet led to accelerated late decline and had no impact on survival. It is possible that the drug facilitates early sprouting that leads to accelerated late decline.


Assuntos
Aminobenzoatos/uso terapêutico , Esclerose Lateral Amiotrófica/tratamento farmacológico , Hipoxantinas/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Superóxido Dismutase/genética , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Camundongos , Camundongos Transgênicos , Superóxido Dismutase-1
10.
Arch Dis Child ; 90(1): 41-2, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15613509

RESUMO

Fifteen patients with intestinal villous atrophy, but simultaneously negative results of antiendomysial antibodies (EMA) were studied. Two patients were finally diagnosed as having coeliac disease. The predictive value of negative results of EMA assessment in children suspected of coeliac disease is high, approaching 86.7%.


Assuntos
Anticorpos/análise , Doença Celíaca/imunologia , Mucosa Intestinal/patologia , Intestino Delgado/patologia , Transglutaminases/imunologia , Adolescente , Atrofia , Biomarcadores/análise , Doença Celíaca/diagnóstico , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Lactente , Masculino , Fibras Musculares Esqueléticas/imunologia , Estudos Retrospectivos , Sensibilidade e Especificidade
11.
Am J Physiol Regul Integr Comp Physiol ; 285(4): R762-9, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12959920

RESUMO

Creatine monohydrate (CrM) supplementation appears to be relatively safe based on data from short-term and intermediate-term human studies and results from several therapeutic trials. The purpose of the current study was to characterize pathological changes after intermediate-term and long-term CrM supplementation in mice [healthy control and SOD1 (G93A) transgenic] and rats (prednisolone and nonprednisolone treated). Histological assessment (18-20 organs/tissues) was performed on G93A mice after 159 days, and in Sprague-Dawley rats after 365 days, of CrM supplementation (2% wt/wt) compared with control feed. Liver histology was also evaluated in CD-1 mice after 300 days of low-dose CrM supplementation (0.025 and 0.05 g x kg-1x day-1) and in Sprague-Dawley rats after 52 days of CrM supplementation (2% wt/wt) with and without prednisolone. Areas of hepatitis were observed in the livers of the CrM-supplemented G93A mice (P < 0.05), with no significant inflammatory lesions in any of the other 18-20 tissues/organs that were evaluated. The CD-1 mice also showed significant hepatic inflammatory lesions (P < 0.05), yet there was no negative effect of CrM on liver histology in the Sprague-Dawley rats after intermediate-term or long-term supplementation nor was inflammation seen in any other tissues/organs (P = not significant). Dietary CrM supplementation can induce inflammatory changes in the liver of mice, but not rats. The observed inflammatory changes in the murine liver must be considered in the evaluation of hepatic metabolism in CrM-supplemented mice. Species differences must be considered in the evaluation of toxicological and physiological studies.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/patologia , Creatina/toxicidade , Suplementos Nutricionais , Fígado/efeitos dos fármacos , Fígado/patologia , Animais , Feminino , Masculino , Camundongos , Camundongos Endogâmicos , Camundongos Transgênicos , Modelos Animais , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Especificidade da Espécie , Superóxido Dismutase/genética
12.
Comp Med ; 50(5): 503-10, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11099133

RESUMO

BACKGROUND AND PURPOSE: Spontaneous animal mutants affected by abnormal formation of myelin in the central nervous system (CNS) are useful in studies on myelinogenesis and remyelination leading to better understanding of cellular and molecular interactions involved in myelin repair. A novel rat mutant, Bouncer Long Evans (LE-bo) is severely dysmyelinated, but with exceptional longevity, and its clinical and pathologic phenotype are described. METHODS: Clinical observations, genetic studies, and determination of longevity were performed in a colony of rats, including carriers of LE-bo phenotype producing the mutant animals. Comprehensive histologic studies were performed on all perfusion-fixed tissues, and ultrastructural examination of the optic nerve and thoracic part of the spinal cord also was done in rats 1 to 14 weeks old. RESULTS: The LE-bo phenotype is characterized by whole body tremor, progressively severe ataxia, and severe seizure activity. The LE-bo phenotype is transferred as an autosomal recessive trait and is stable. The LE-bo rat can survive in good health beyond 45 weeks. Neuropathologic changes include severe global dysmyelination, with thin uncompacted myelin sheaths in young rats forming no major dense line, whereas the myelin sheaths of the peripheral nervous system appear normal. Oligodendrocytes degenerate with apparently progressing accumulation of membranous material in the perikaryon. Large numbers of immature glial cells were detected in the CNS of LE-bo rats at 4 to 14 weeks. CONCLUSION: The LE-bo rat is severely dysmyelinated due to inability of its oligodendrocytes to form myelin sheaths. Similarities of the LE-bo rat and Long Evans Shaker (les) rat neuropathologic features, such as severe dysmyelination, lack of major dense line in uncompacted myelin sheaths, apparent proliferation of oligodendroglial cells, and considerable longevity, are striking and suggest that a LE-bo mutation may functionally affect the myelin basic protein gene.


Assuntos
Sistema Nervoso Central/patologia , Bainha de Mielina/fisiologia , Ratos Long-Evans/fisiologia , Ratos Mutantes/fisiologia , Animais , Encéfalo/patologia , Encéfalo/ultraestrutura , Sistema Nervoso Central/ultraestrutura , Feminino , Histocitoquímica/veterinária , Masculino , Microscopia Eletrônica/veterinária , Bainha de Mielina/genética , Bainha de Mielina/patologia , Oligodendroglia/patologia , Oligodendroglia/ultraestrutura , Nervo Óptico/patologia , Nervo Óptico/ultraestrutura , Ratos , Ratos Long-Evans/genética , Ratos Mutantes/genética , Nervo Isquiático/patologia , Nervo Isquiático/ultraestrutura , Medula Espinal/patologia , Medula Espinal/ultraestrutura , Tremor/veterinária
13.
J Neurosci ; 19(9): 3404-13, 1999 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-10212300

RESUMO

Our understanding of myelination has been greatly enhanced via the study of spontaneous mutants that harbor a defect in a gene encoding one of the major myelin proteins (myelin mutants). In this study, we describe a unique genetic defect in a new myelin mutant called the Long Evans shaker (les) rat that causes severe dysmyelination of the CNS. Myelin deficits result from disruption of the myelin basic protein (Mbp) gene caused by the insertion of an endogenous retrotransposon [early transposons (ETn) element] into a noncoding region (intron 3) of the gene. The ETn element alters the normal splicing dynamics of MBP mRNA, leading to a dramatic reduction in the levels of full-length isoforms (<5% of normal) and the appearance of improperly spliced, chimeric transcripts. Although these aberrant transcripts contain proximal coding regions of the MBP gene (exons 1-3), they are unable to encode functional proteins required to maintain the structural integrity of the myelin sheath. These chimeric transcripts seem capable, however, of producing the necessary signal to initiate and coordinate myelin gene expression because normal numbers of mature oligodendrocytes synthesizing abundant levels of other myelin proteins are present in the mutant CNS. The les rat is thus an excellent model to study alternative functions of MBP beyond its well characterized role in myelin compaction.


Assuntos
Encéfalo/metabolismo , Proteína Básica da Mielina/genética , Splicing de RNA , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Retroelementos , Nervo Isquiático/metabolismo , Medula Espinal/metabolismo , Animais , Sequência de Bases , Íntrons , Dados de Sequência Molecular , Proteína Básica da Mielina/biossíntese , Proteína Básica da Mielina/deficiência , Isoformas de Proteínas/biossíntese , Isoformas de Proteínas/genética , Ratos , Ratos Long-Evans , Ratos Mutantes , Proteínas Recombinantes de Fusão/biossíntese , Transcrição Gênica
14.
J Neurocytol ; 27(8): 581-91, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10405025

RESUMO

The Long Evans shaker (les) rat is a recently identified CNS myelin mutant with an autosomal recessive mode of inheritance. Although scattered myelin sheaths are present in some areas of the CNS, most notably the ventral spinal cord in the young neonatal rat, this myelin is gradually lost, and 8-12 weeks little myelin is present throughout the CNS. Despite this severe myelin deficiency, some mutants may live beyond one year of age. Rare, thin myelin sheaths that are present early in development lack myelin basic protein (MBP) and on ultrastructural examination are poorly compacted and lack a major dense line. Many oligodendrocytes develop an accumulation of vesicles and membranous bodies, but no abnormal cell death is observed. In the optic nerve, cell kinetic studies show an increase in proliferation at early time points in les, while total glial cell counts are also increased in les from 2 months of age. In situ hybridization studies demonstrate that the numbers of mature oligodendrocytes are similar to controls early in life and increase with time compared to controls. There is both a progressive astrocyte hypertrophy and microgliosis. While les has a mutation in the myelin basic protein (mbp) gene, it is dissimilar in both genotype and phenotype to the previously described mbp mouse mutants, shiverer (shi) and shiverer(mld). Unlike shi and its allele, where myelin increases with time and oligodendrocytes become ultrastructurally normal, les oligodendrocytes are permanently disabled, continue to demonstrate cytoplasmic abnormalities, and fail to produce myelin beyond the first weeks of life.


Assuntos
Doenças Desmielinizantes/patologia , Animais , Encéfalo/metabolismo , Encéfalo/patologia , Tamanho Celular , Doenças Desmielinizantes/genética , Imuno-Histoquímica , Hibridização In Situ , Microscopia Eletrônica , Proteína Básica da Mielina/deficiência , Proteína Básica da Mielina/genética , Proteína Básica da Mielina/metabolismo , Bainha de Mielina/metabolismo , Bainha de Mielina/patologia , Bainha de Mielina/ultraestrutura , Oligodendroglia/metabolismo , Oligodendroglia/patologia , Oligodendroglia/ultraestrutura , Ratos , Ratos Long-Evans , Ratos Mutantes , Medula Espinal/metabolismo , Medula Espinal/patologia , Medula Espinal/ultraestrutura
15.
Pol Merkur Lekarski ; 5(27): 151-4, 1998 Sep.
Artigo em Polonês | MEDLINE | ID: mdl-10101484

RESUMO

Normal endothelium cells play a huge role in small blood vessels function. It's not only physical barrier between blood and surrounding structures, but also producers a lot vasodilatators and vasodepresors. It's controlled by blood humoral factors plaing important role on blood circulation physiology. Endothelium cells injury gives its function abnormality local and general as well. The main injury factor is hypertension, which provides to endothelium disfunction with vasopressors level growth which induces hypertension. Also primary endothelial injury induces hypertension and atherogenesis.


Assuntos
Anti-Hipertensivos/farmacologia , Anti-Hipertensivos/uso terapêutico , Citoproteção/fisiologia , Endotélio/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Humanos
16.
Clin Invest Med ; 20(5): 327-38, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9336658

RESUMO

OBJECTIVE: To determine the protective effects of perindopril treatment in the prevention of stroke and the relation between preventive effects and the histopathology of the brain and kidneys in male stroke-prone spontaneously hypertensive rats (SHRSP). DESIGN: Prospective animal study. INTERVENTIONS: Beginning at 6 weeks of age, SHRSP were treated with either distilled water (control) or perindopril for different periods (8, 12 or 24 weeks) and at different dosages (1 or 4 mg/kg per day). OUTCOME MEASURES: Regular determination of systolic blood pressure, heart rate and body weight until death; at necropsy, macroscopic and microscopic examinations of the brain and kidneys. RESULTS: Control SHRSP developed severe hypertension (up to 250 mm Hg) by 11 weeks of age and died of stroke within 14 weeks of age. Treatment with perindopril (4 mg/kg per day for 8 or 12 weeks or either 1 or 4 mg/kg per day for 24 weeks) attenuated the blood pressure rise and prevented stroke. In untreated SHRSP, the last blood pressure measurement before the first stroke sign was significantly higher than in SHRSP of the same age treated with perindopril. Withdrawal of the treatment resulted in a rise in blood pressure in all the treatment groups, to approximately 260 mm Hg within 4 weeks. Most of the rats treated for 8 or 12 weeks died within 10 weeks after withdrawal of treatment, whereas those treated for 24 weeks survived up to 43 weeks of age. Treatment also prevented damage to the brain and kidneys and reduced the severity of lesions in the brain and kidneys after treatment withdrawal. CONCLUSION: Treatment of SHRSP with perindopril prevents stroke through the suppression of blood pressure rise and prevention of tissue damage in the brain and the kidneys. Longer treatment decreased the rate of mortality due to stroke after the withdrawal of treatment as well as the severity of lesions in the brain and kidneys.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Transtornos Cerebrovasculares/prevenção & controle , Indóis/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/administração & dosagem , Animais , Pressão Sanguínea , Peso Corporal , Encéfalo/patologia , Córtex Cerebral/irrigação sanguínea , Córtex Cerebral/patologia , Transtornos Cerebrovasculares/mortalidade , Transtornos Cerebrovasculares/patologia , Frequência Cardíaca , Hipertensão/prevenção & controle , Indóis/administração & dosagem , Rim/patologia , Nefropatias/etiologia , Nefropatias/patologia , Nefropatias/prevenção & controle , Masculino , Perindopril , Estudos Prospectivos , Ratos , Ratos Endogâmicos SHR , Taxa de Sobrevida , Fatores de Tempo
17.
Exp Mol Pathol ; 64(3): 173-83, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9439482

RESUMO

Previous studies on male stroke-prone spontaneously hypertensive rats (SHRSP) have shown that a high-salt diet accelerated the onset of hypertension and stroke, resulting in an increased mortality rate at a younger age. The purpose of this study was to examine whether a similar effect is present in female SHRSP. After weaning at 4 weeks of age, 32 female SHRSP were placed on a Japanese-style rat diet containing either 0.3% NaCl or 4% NaCl. Blood pressure (BP), heart rate, and body weight were measured weekly. Beginning at 9 weeks of age, the SHRSP on the 4% NaCl diet began to show a consistently and significantly higher BP than those in the 0.3% NaCl group, reaching an average BP of 245 +/- 9 mmHg at 16 weeks of age as compared to 184 +/- 3 mmHg in the 0.3% NaCl group. Some female SHRSP in the 4% NaCl group started to exhibit behavioral signs of stroke at 12 weeks of age and 100% mortality was found by 20 weeks. There was 0% mortality in the 0.3% NaCl group at that age. A positive correlation was found between the age at which BP surpassed 220 mmHg and the age death occurred due to stroke. No significant difference was noted in the heart rate or body weight measurements between the two groups. The increased mortality rate in the 4% NaCl diet group was accompanied by organ damage as evidenced by the presence of left ventricular hypertrophy, edematous kidneys, renal malfunction, kidney lesions, and cerebral lesions in these female SHRSP. It is concluded that a high-salt diet exacerbates hypertension and caused an increased mortality rate. This increased mortality rate was associated with an increased left ventricular hypertrophy, kidney damage and subsequent malfunction, and cerebrovascular lesions in these female SHRSP.


Assuntos
Transtornos Cerebrovasculares/etiologia , Hemodinâmica , Hipertensão/etiologia , Sódio na Dieta/efeitos adversos , Envelhecimento , Animais , Pressão Sanguínea , Peso Corporal , Córtex Cerebral/patologia , Transtornos Cerebrovasculares/mortalidade , Transtornos Cerebrovasculares/patologia , Feminino , Frequência Cardíaca , Hipertensão/mortalidade , Hipertensão/patologia , Rim/patologia , Tamanho do Órgão , Ratos , Ratos Endogâmicos SHR , Taxa de Sobrevida
18.
Lab Anim Sci ; 45(5): 547-53, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8569154

RESUMO

Tremors were observed in 15 Long Evans rats beginning at 10 to 12 days of age. These were followed by progressively worsening ataxia, hind limb paresis, episodes of immobility, and seizures by 5 to 14 weeks. Gross lesions were not observed at necropsy in rats euthanized and perfused at 4 to 16 weeks of age. Neurohistologic examination revealed dysmyelination in the central nervous system. Astrogliosis in the white matter with marked increase of expression of the glial fibrillary acid protein marker was accompanied by diffuse microgliosis. Scattered glial cells, interpreted to be oligodendrocytes, contained minute periodic acid-Schiff-positive cytoplasmic granules. Large mineralized periodic acid-Schiff-positive and laminated structures were observed in the cerebellar white matter, midbrain, and thalamus of rats over 6 weeks old. Neuronal degeneration and loss was evident in the cortex, hippocampus, and midbrain. Large axonal spheroids were found in the ventral and lateral funiculi of the spinal cord. An ultrastructural study of four affected rats revealed an almost complete absence of myelinated axons and normal sheaths, and degeneration and necrosis of oligodendrocytes. The Long Evans shaker rat represents a novel myelin mutant with a remarkable survival period and appears to have an autosomal recessive mode of inheritance.


Assuntos
Doenças Desmielinizantes/veterinária , Modelos Animais de Doenças , Ratos Mutantes/genética , Doenças dos Roedores/genética , Animais , Axônios/ultraestrutura , Corpo Caloso/patologia , Citoplasma/patologia , Doenças Desmielinizantes/genética , Doenças Desmielinizantes/patologia , Feminino , Genes Recessivos , Masculino , Mutação , Bainha de Mielina/patologia , Bainha de Mielina/ultraestrutura , Degeneração Neural , Oligodendroglia/patologia , Oligodendroglia/ultraestrutura , Linhagem , Ratos , Doenças dos Roedores/patologia , Medula Espinal/patologia , Tálamo/patologia
19.
Vet Pathol ; 32(4): 437-40, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7483223

RESUMO

Five dogs euthanatized because of refractory seizures were found to have hematopoietic elements in the interstitium of the choroid plexus at the level of the fourth ventricle. None of the dogs had significant hematologic or cerebrospinal fluid abnormalities. The extramedullary hematopoiesis was confined to the central nervous system and consisted of megakaryocytes, immature granulocytes, and rubricytes in two dogs and of one predominant cell population in each of the other three dogs. These findings are unique, and factors possibly contributing to the formation of a hematopoietic inductive microenvironment in the choroid plexus are cytokine-neurokine homologies, locally altered vascular supply, and aberrant functioning of bone marrow-derived central nervous system macrophages.


Assuntos
Plexo Corióideo/patologia , Plexo Corióideo/fisiologia , Doenças do Cão/patologia , Hematopoese Extramedular/fisiologia , Convulsões/veterinária , Animais , Líquido Cefalorraquidiano/citologia , Cães , Feminino , Granulócitos/patologia , Macrófagos/patologia , Masculino , Megacariócitos/patologia , Convulsões/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...